Cape Cod Five Cents Savings Bank Boosted Texas Instrs (TXN) Stake By $1.48 Million; Aevi Genomic Medicine (GNMX) Sellers Increased By 2.11% Their Shorts

June 20, 2018 - By Michael Collier

Texas Instruments Incorporated (NASDAQ:TXN) Logo

Cape Cod Five Cents Savings Bank increased Texas Instrs Inc (TXN) stake by 120.62% reported in 2018Q1 SEC filing. Cape Cod Five Cents Savings Bank acquired 14,408 shares as Texas Instrs Inc (TXN)’s stock rose 1.76%. The Cape Cod Five Cents Savings Bank holds 26,353 shares with $2.74 million value, up from 11,945 last quarter. Texas Instrs Inc now has $112.77 billion valuation. The stock increased 1.06% or $1.21 during the last trading session, reaching $114.87. About 1.52 million shares traded. Texas Instruments Incorporated (NASDAQ:TXN) has risen 38.09% since June 20, 2017 and is uptrending. It has outperformed by 25.52% the S&P500. Some Historical TXN News: ; 24/04/2018 – After-hours buzz: TXN, WYNN, EW & more; 24/04/2018 – TI reports 1Q18 financial results and shareholder returns; 24/04/2018 – Texas Instruments 1Q Rev $3.79B; 24/04/2018 – Texas Instruments Sees 2Q Rev $3.78B-$4.1B; 24/04/2018 – Texas Instruments Sees 2Q EPS $1.19-EPS $1.39; 03/05/2018 – TI COO Brian Crutcher to speak at J.P. Morgan investor conference; 24/04/2018 – Texas Instruments’ profit rises 37 percent in first quarter; 13/04/2018 – Texas Instruments Senior VP of Technology & Manufacturing Kevin J. Ritchie to Retire Nov. 1; 24/04/2018 – ANALOG DEVICES, XILINX GAIN AFTER TEXAS INSTRUMENTS’ REV. BEAT; 24/04/2018 – TEXAS INSTRUMENTS 1Q EPS INCL 14C/SHR TAX-RELATED BENEFITS

Aevi Genomic Medicine Inc (NASDAQ:GNMX) had an increase of 2.11% in short interest. GNMX’s SI was 416,800 shares in June as released by FINRA. Its up 2.11% from 408,200 shares previously. With 128,400 avg volume, 3 days are for Aevi Genomic Medicine Inc (NASDAQ:GNMX)’s short sellers to cover GNMX’s short positions. The stock increased 3.39% or $0.04 during the last trading session, reaching $1.22. About 74,985 shares traded. Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) has risen 37.50% since June 20, 2017 and is uptrending. It has outperformed by 24.93% the S&P500. Some Historical GNMX News: ; 15/05/2018 – Aevi Genomic Medicine 1Q Loss/Shr 15c; 13/03/2018 – AEVI GENOMIC MEDICINE – HAD CASH AND CASH EQUIVALENTS OF $33.73 MLN AT DECEMBER 31, 2017; 07/03/2018 – AEVI GENOMIC MEDICINE INC – FINANCIAL AND OTHER TERMS OF DEAL WERE NOT DISCLOSED; 13/03/2018 – AEVI GENOMIC MEDICINE INC – EXPECTS CURRENT CASH BALANCE TO FUND OPERATIONS INTO EARLY 2019; 13/03/2018 – Aevi Genomic Medicine 4Q Loss/Shr 13c; 15/05/2018 – AEVI GENOMIC MEDICINE IN UP TO $20M EQUITY DISTRIBUTION PACT; 07/03/2018 – AEVI GENOMIC MEDICINE – SIGNING OF OPTION AGREEMENT FOR EARLY STAGE MONOCLONAL ANTIBODY PROGRAM IN AN ULTRA-ORPHAN PEDIATRIC INDICATION; 15/05/2018 – AEVI GENOMIC MEDICINE FILES TO OFFER $50M IN MIXED SECURITIES; 07/03/2018 – AEVI GENOMIC MEDICINE INC – EXPANDED COLLABORATION WITH KYOWA HAKKO KIRIN CO LTD; 19/04/2018 – DJ Aevi Genomic Medicine Inc, Inst Holders, 1Q 2018 (GNMX)

Another recent and important Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) news was published by Streetinsider.com which published an article titled: “Aevi Genomic Medicine (GNMX) Reports Update to Size Sample for Part A of Phase 2 ASCEND Clinical Trial in ADHD” on June 12, 2018.

Aevi Genomic Medicine, Inc., a clinical stage biopharmaceutical company, researches and develops novel therapies for pediatric onset and life-altering diseases in the United States. The company has market cap of $72.39 million. The Company’s lead product candidates include AEVI-001, a glutamatergic neuromodulator, which is in Phase II/III SAGA trial for a genetically-defined subset of adolescent attention deficit hyperactivity disorder patients with specific mutations in their metabotropic glutamate receptor gene network; and AEVI-002, an anti-light monoclonal antibody that is in Phase I clinical trial for use in severe pediatric onset crohnÂ’s disease. It currently has negative earnings. The firm was formerly known as Medgenics, Inc. and changed its name to Aevi Genomic Medicine, Inc. in December 2016.

Among 42 analysts covering Texas Instruments (NASDAQ:TXN), 19 have Buy rating, 3 Sell and 20 Hold. Therefore 45% are positive. Texas Instruments had 119 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Sunday, August 27 with “Buy”. The company was maintained on Wednesday, August 30 by Jefferies. As per Wednesday, February 3, the company rating was downgraded by Goldman Sachs. The stock has “Market Perform” rating by Bernstein on Tuesday, July 26. The rating was downgraded by B. Riley & Co on Thursday, October 22 to “Neutral”. The rating was maintained by Stifel Nicolaus with “Hold” on Wednesday, October 25. Cowen & Co maintained Texas Instruments Incorporated (NASDAQ:TXN) rating on Thursday, January 28. Cowen & Co has “Market Perform” rating and $56 target. The firm has “Buy” rating given on Wednesday, April 25 by Citigroup. Stifel Nicolaus maintained the shares of TXN in report on Thursday, January 18 with “Hold” rating. The firm earned “Outperform” rating on Monday, August 3 by RBC Capital Markets.

More news for Texas Instruments Incorporated (NASDAQ:TXN) were recently published by: Gurufocus.com, which released: “Semiconductor Companies Showing Good Value Potential Despite Trade War Fears” on June 19, 2018. Fool.com‘s article titled: “Here’s Why Texas Instruments Inc. Shares Rose 10.3% In May” and published on June 07, 2018 is yet another important article.

Cape Cod Five Cents Savings Bank decreased Verizon Communications Inc (NYSE:VZ) stake by 8,111 shares to 98,882 valued at $4.73 million in 2018Q1. It also reduced Adobe Sys Inc (NASDAQ:ADBE) stake by 4,878 shares and now owns 28,015 shares. Bb&T Corp (NYSE:BBT) was reduced too.

Since January 25, 2018, it had 0 insider purchases, and 24 selling transactions for $122.64 million activity. Another trade for 18,571 shares valued at $2.02 million was sold by ANDERSON STEPHEN A.. Van Haren Julie also sold $313,589 worth of Texas Instruments Incorporated (NASDAQ:TXN) shares. BABB RALPH W JR also sold $2.98 million worth of Texas Instruments Incorporated (NASDAQ:TXN) on Thursday, February 1. CRUTCHER BRIAN T had sold 267,201 shares worth $29.68M. XIE BING had sold 15,877 shares worth $1.73M. Shares for $2.63 million were sold by Ilan Haviv. The insider RITCHIE KEVIN J sold $6.79M.

Texas Instruments Incorporated (NASDAQ:TXN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>